4//SEC Filing
HeartWare International, Inc. 4
Accession 0001209191-16-102406
CIK 0001389072operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:12 PM ET
Size
9.7 KB
Accession
0001209191-16-102406
Insider Transaction Report
Form 4
LaRose Jeffrey
Chief Scientifc Officer
Transactions
- Sale
Common Stock
2016-02-24$32.41/sh−205$6,644→ 11,636 total - Exercise/Conversion
Restricted Stock Unit
2016-02-23−750→ 10,450 totalFrom: 2016-02-23Exp: 2016-02-23→ Common Stock (750 underlying) - Exercise/Conversion
Common Stock
2016-02-23+750→ 11,841 total
Footnotes (4)
- [F1]On February 23, 2015, the reporting person was granted restricted stock units to acquire 3,000 shares of HeartWare International common stock. The award vests in four equal annual installments commencing on February 23, 2016. On February 23, 2016, 750 shares of common stock were issued to the reporting person.
- [F2]These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The sale proceeds were utilized to pay all payroll taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
- [F3]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $32.25 to $32.57. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
Documents
Issuer
HeartWare International, Inc.
CIK 0001389072
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389072
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:12 PM ET
- Size
- 9.7 KB